ATRA vs ICE · rev $128.9M vs P/E 37, rev $12.64B
Atara Biotherapeutics Inc (ATRA) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
ATRA currently screens at market cap $87.1M. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the ATRA and ICE stock pages for the full models.
Not investment advice.